Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells

Rickinson, 1996, Epstein-Barr virus., Virology., 2397 Bird, 1981, Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus induced B-cell lines., Nature., 289, 300, 10.1038/289300a0 Yao, 1985, A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals., Int J Cancer., 35, 35, 10.1002/ijc.2910350107 Lewin, 1987, Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth., Int J Cancer., 39, 472, 10.1002/ijc.2910390411 Rickinson, 1981, Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line., Int J Cancer., 27, 593, 10.1002/ijc.2910270505 Hanto, 1983, Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation., Ann Surg., 198, 356, 10.1097/00000658-198309000-00012 Hanto, 1985, Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation., Transplantation., 39, 461, 10.1097/00007890-198505000-00001 Nalesnik, 1988, The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine-prednisone immunosuppression., Am J Pathol., 133, 173 Orazi, 1997, Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features., Am J Clin Pathol., 107, 419, 10.1093/ajcp/107.4.419 Shapiro, 1988, Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation., Blood., 71, 1234, 10.1182/blood.V71.5.1234.1234 Hongeng, 1997, Outcomes of transplantation with matched-siblings and unrelated-donor bone marrow in children with leukemia., Lancet., 350, 767, 10.1016/S0140-6736(97)03098-5 Heslop, 1997, Adoptive immunotherapy of EBV lymphoproliferative diseases., Immunol Rev., 157, 217, 10.1111/j.1600-065X.1997.tb00984.x Deeg, 1998, Malignancies after hematopoietic stem cell transplantation: many questions, some answers., Blood., 91, 1833, 10.1182/blood.V91.6.1833 O'Reilly, 1997, Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts., Immunol Rev., 157, 195, 10.1111/j.1600-065X.1997.tb00983.x Rooney, 1998, Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients., Blood., 92, 1549, 10.1182/blood.V92.5.1549 Papadopoulos, 1994, Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation., N Engl J Med., 330, 1185, 10.1056/NEJM199404283301703 Heslop, 1996, Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes., Nature Med., 2, 551, 10.1038/nm0596-551 Rooney, 1995, Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation., Lancet., 345, 9, 10.1016/S0140-6736(95)91150-2 Rooney, 1995, Early identification of Epstein-Barr virus associated post-transplant lymphoproliferative disease., Br J Haematol., 89, 98, 10.1111/j.1365-2141.1995.tb08904.x Riddler, 1994, Increased levels of circulating Epstein-Barr virus (EBV) infected lymphocytes and decreased EBV nuclear antigen antibody response are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipients., Blood., 84, 972, 10.1182/blood.V84.3.972.972 Savoie, 1994, Direct correlation between the load of Epstein-Barr virus infected lymphocytes and the peripheral blood of pediatric transplant patients at risk of lymphoproliferative disease., Blood., 83, 2715, 10.1182/blood.V83.9.2715.2715 Olerup, 1992, HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in two hours: an alternative to serological typing including donor recipient matching in cadaveric transplantation., Tissue Antigens., 1992, 225, 10.1111/j.1399-0039.1992.tb01940.x Oakhill, 1996, Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukemia in second complete remission., Br J Haematol., 94, 574, 10.1046/j.1365-2141.1996.d01-1834.x Ringdén, 1989, Bone marrow transplantation in children., Clin Transpl., 3, 12 Ringdén, 1998, Low incidence of acute graft-versus-host disease using unrelated HLA-A, -B and -DR compatible donors and conditioning including anti-T-cell antibodies., Transplantation., 66, 620, 10.1097/00007890-199809150-00013 Söderahl, 1988, Cadaveric bone marrow and spleen cells for transplantation., Bone Marrow Transplant., 21, 79, 10.1038/sj.bmt.1701039 Lundgren, 1986, Six months prophylaxis with acyclovir in bone marrow transplant recipients., Bone Marrow Transplant., 1(Suppl.), 54 Ljungman, 1998, Results of different strategies for reducing CMV associated mortality in allogeneic stem cell transplantation., Transplantation., 66, 1330, 10.1097/00007890-199811270-00012 Ringdén, 1991, Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomised trial in adult leukemic marrow recipients., Bone Marrow Transplant., 7, 221 Winiarski, 1998, Engraftment and chimerism, particularly on T- and B-cells in children undergoing bone marrow transplantation., Ped Transpl., 2, 150 Chen, 1995, A subpopulation of latently EBV infected normal B-cells resembles Burkitt lymphoma (BL) in expressing EBNA1 but not EBNA2 or LMP1., J Virol., 69, 3752, 10.1128/JVI.69.6.3752-3758.1995 Miller, 1973, Release of infectious Epstein-Barr virus by transformed marmoset leukocytes., Proc Natl Acad Sci USA., 70, 190, 10.1073/pnas.70.1.190 Levitsky, 1997, Selection and maintenance of an oligoclonal peptide specific cytotoxic T-cell repertoire in the course of persistent infection with Epstein-Barr virus., J Immunol., 161, 594, 10.4049/jimmunol.161.2.594 Gavioli, 1993, Multiple HLA A11 restricted CTL epitopes of different immunogenicity in the Epstein-Barr virus (EBV) encoded nuclear antigen-4 (EBNA4)., J Virol., 67, 1572, 10.1128/JVI.67.3.1572-1578.1993 Miyashita, 1995, A novel form of Epstein-Barr virus latency in normal B cells in vivo., Cell., 80, 593, 10.1016/0092-8674(95)90513-8 Winiarski, 1996, Bone marrow transplantation in children using unrelated donors at Huddinge Hospital., Acta Paediatr., 85, 327, 10.1111/j.1651-2227.1996.tb14026.x Snapper, 1998, Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation., Cell., 9, 81 Elenitoba-Jonsson, 1997, Lymphoproliferative disorders associated with congenital immunodeficiencies., Semin Diagn Pathol., 14, 35 Ozsahin, 1996, Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center., J Pediatr., 129, 238, 10.1016/S0022-3476(96)70248-2 Sasahara, 1998, Epstein-Barr virus-associated lymphoproliferative disorder after unrelated bone marrow transplantation in a young child with Wiskott-Aldrich syndrome., Pediatr Hematol Oncol., 15, 347, 10.3109/08880019809014019 Binks, 1998, Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome., Eur J Immunol., 28, 3259, 10.1002/(SICI)1521-4141(199810)28:10<3259::AID-IMMU3259>3.0.CO;2-B Borrows, 1994, An alloresponse in human is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease., J Exp Med., 179, 1155, 10.1084/jem.179.4.1155 Burrows, 1995, T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen., J Exp Med., 182, 1703, 10.1084/jem.182.6.1703 Banchereau, 1998, Dendritic cells and the control of immunity., Nature., 392, 245, 10.1038/32588